Research Article
Establishment and Validation of a Nomogram Prognostic Model for Epithelioid Hemangioendothelioma
Table 1
General clinical characteristics of the EHE patients.
| | Characteristic | All patients (%) | Training group (%) | Validation group (%) | | |
| | Age | | | | 1.608 | 0.109 | | | | | | | | | Sex | | | | 0.000 | 1.000 | | Female | 300 (58.9) | 211 (58.6) | 89 (58.6) | | | | Male | 212 (41.1) | 149 (41.4%) | 63 (41.4%) | | | | Race | | | | 4.836 | 0.089 | | Black | 56 (10.9) | 43 (11.9%) | 13 (8.6%) | | | | Other (Asian) | 35 (6.8) | 30 (8.3%) | 6 (3.9%) | | | | White | 420 (82.0) | 287 (79.7%) | 133 (87.5%) | | | | Degree of differentiation | | | | 0.962 | 0.644 | | Poor (grade III or IV) | 47 (9.2) | 35 (9.7%) | 12 (7.9%) | | | | Unknown | 378 (73.8) | 267 (74.2%) | 111 (73%) | | | | Good (grade I or II) | 87 (17.0) | 58 (16.1%) | 29 (19.1%) | | | | Staging | | | | 1.543 | 0.677 | | Distant | 187 (36.5) | 133 (36.9%) | 54 (35.5%) | | | | Localized | 146 (28.5) | 104 (28.9%) | 42 (27.6%) | | | | Regional | 98 (19.1) | 64 (17.8%) | 34 (22.4%) | | | | Unknown | 81 (15.8) | 59 (16.4%) | 22 (14.5%) | | | | Primary location | | | | 3.38 | 0.50 | | Bone (soft tissue) | 121 (23.6) | 87 (24.2%) | 34 (22.4%) | 1 | 0 | | Head and neck | 40 (7.8) | 29 (8.1%) | 11 (7.2%) | | | | Liver | 131 (25.6) | 84 (23.3%) | 47 (30.9%) | | | | Lung | 124 (24.2) | 89 (24.7%) | 35 (23%) | | | | Other parts | 98 (18.8) | 71 (19.7%) | 25 (16.4%) | | | | Surgery | | | | 2.117 | 0.359 | | No | 217 (42.4) | 149 (41.4%) | 68 (44.7%) | | | | Unknown | 32 (6.3) | 26 (7.2%) | 6 (3.9%) | | | | Yes | 263 (51.4) | 185 (51.4%) | 78 (51.3%) | | | | Chemotherapy | | | | 0.076 | 0.828 | | No | 373 (72.9) | 261 (72.5%) | 112 (73.7%) | | | | Yes | 139 (27.1) | 99 (27.5%) | 40 (26.3%) | | | | Radiotherapy | | | | 1.722 | 0.215 | | No | 392 (76.6) | 267 (74.2%) | 121 (79.6%) | | | | Yes | 120 (23.4) | 93 (25.8%) | 31 (20.4%) | | |
|
|
EHE: epithelioid hemangioendothelioma; SD: standard deviation.
|
